Evidence map›Paper›PMID 26848712›Full record

ArticleJournal of thrombosis and haemostasis : JTH2016

Non-genomic activities of retinoic acid receptor alpha control actin cytoskeletal events in human platelets.

M T Rondina, M Freitag, F G Pluthero, W H A Kahr, J W Rowley, L W Kraiss, Z Franks, G A Zimmerman, A S Weyrich, H Schwertz

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. A New Role of NAP1L1 in Megakaryocytes and Human Platelets.International journal of molecular sciences · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

M T RondinaMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
M FreitagDepartment of Immunology and Transfusion Medicine, University of Greifswald, Greifswald, Germany.
F G PlutheroProgram in Cell Biology, Research Institute, Hospital for Sick Children, Toronto, ON, Canada.
W H A KahrProgram in Cell Biology, Research Institute, Hospital for Sick Children, Toronto, ON, Canada.
J W RowleyMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
L W KraissMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
Z FranksMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
G A ZimmermanMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
A S WeyrichMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
H SchwertzMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
University of Utah · USHospital for Sick Children · CAUniversität Greifswald · DEUniversity of Toronto · CA

Funding

Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S, ZIMMERMAN, GUY A. · 2012 to 2016
$12.9M
TRANSLATIONAL EVENTS IN PLATELETSR01HL066277 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2001 to 2012
$3.8M
Molecular Interactions of Myeloid Cells with EndotheliumR37HL044525 · NHLBI · UNIVERSITY OF UTAH · PI ZIMMERMAN, GUY A. · 2004 to 2013
$3.5M
The Effects of ART on Platelets and HIV-Associated ThrombosisR01HL126547 · NHLBI · UNIVERSITY OF UTAH · PI PLANELLES, VICENTE, RONDINA, MATTHEW THOMAS · 2014 to 2017
$3.0M
Translational Control of Rapid Endothelial ResponsesR01HL075507 · NHLBI · UNIVERSITY OF UTAH · PI KRAISS, LARRY W · 2004 to 2008
$1.8M
Platelet Immune Responses in Aging and InfluenzaR01AG048022 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2014 to 2018
$1.8M
MOLECULAR INTERACTIONS OF MYELOID CELLS WITH ENDOTHELIUMR01HL044525 · NHLBI · UNIVERSITY OF UTAH · PI ZIMMERMAN, GUY A. · 1990 to 2003
$1.2M
The Platelet Metabolome in ObesityK01GM103806 · NIGMS · UNIVERSITY OF UTAH · PI ROWLEY, JESSE · 2012 to 2016
$802k
Novel Platelet Functions in Sepsis and Venous ThromboembolismK23HL092161 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2009 to 2013
$775k
The Regulation of Inflammatory Gene Responses in AgingR03AG040631 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2011 to 2012
$149k
CIHR MOP-259952CIHR MOP-81208NHLBI NIH HHS K23 HL092161NHLBI NIH HHS R01 HL044525NHLBI NIH HHS R01 HL066277NHLBI NIH HHS R01 HL075507NHLBI NIH HHS R01 HL126547NHLBI NIH HHS R37 HL044525NHLBI NIH HHS U54 HL112311NIA NIH HHS R01 AG048022NIA NIH HHS R03 AG040631NIGMS NIH HHS K01 GM103806
6 · The paper itself

Abstract

unlabelledEssentials Platelets employ proteins/signaling pathways traditionally thought reserved for nuclear niche. We determined retinoic-acid-receptor alpha (RARα) expression and function in human platelets. RARα/actin-related protein-2/3 complex (Arp2/3) interact via non-genomic signaling in platelets. RARα regulates Arp2/3-mediated actin cytoskeletal dynamics and platelet spreading. SUMMARY: Background Platelets utilize proteins and pathways classically reserved for the nuclear niche. Methods We determined whether human platelets express retinoic-acid-receptor family members, traditionally thought of as nuclear transcription factors, and deciphered the function of RARα. Results We found that RARα is robustly expressed in human platelets and megakaryocytes and interacts directly with actin-related protein-2/3 complex (Arp2/3) subunit 5 (Arp2/3s5). Arp2/3s5 co-localized with RARα in situ and regulated platelet cytoskeletal processes. The RARα ligand all-trans retinoic acid (atRA) disrupted RARα-Arp2/3 interactions. When isolated human platelets were treated with atRA, rapid cytoskeletal events (e.g. platelet spreading) were inhibited. In addition, when platelets were cultured for 18 h in the presence of atRA, actin-dependent morphological changes (e.g. extended cell body formation) were similarly inhibited. Using in vitro actin branching assays, RARα and Arp2/3-regulated complex actin branch formation was demonstrated. Consistent with inhibition of cytoskeletal processes in platelets, atRA, when added to this branching assay, resulted in dysregulated actin branching. Conclusion Our findings identify a previously unknown mechanism by which RARα regulates Arp2/3-mediated actin cytoskeletal dynamics through a non-genomic signaling pathway. These findings have broad implications in both nucleated and anucleate cells, where actin cytoskeletal events regulate cell morphology, movement and division.

Indexed as

Actin-Related Protein 2Actin-Related Protein 3ActinsAntigens, CD34ApoptosisBlood PlateletsCytoskeletonGene Expression ProfilingHealthy VolunteersHumansMass SpectrometryMicroscopy, FluorescenceRetinoic Acid Receptor alphaSignal TransductionTranscription FactorsActin-Related Protein 2Actin-Related Protein 3ActinsACTR2 protein, humanACTR3 protein, humanAntigens, CD34RARA protein, humanRetinoic Acid Receptor alphaTranscription Factorsactinactin-related protein 2-3 complexblood plateletsprotein interaction domains and motifsretinoic acid receptors

Identifiers

PMID26848712
PMCPMC5497578
OpenAlexW2339346602

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.